UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.

Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

Current prostate cancer tests may fail to detect early-stage disease in transgender women, potentially leading to delayed diagnosis and treatment.

A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...

MONDAY, July 1, 2024 -- Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer...

THURSDAY, June 27, 2024 -- Acupuncture can help breast cancer patients deal with the hot flashes that often accompany hormone therapy, a new clinical...

Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...

In a pooled analysis of three clinical trials, acupuncture significantly reduced hot flashes and other hormonal side effects of endocrine therapy...

Introducing a novel approach to enhance checkpoint inhibitor therapy for cancer, promising improved treatment outcomes and efficacy in clinical...

MONDAY, June 24, 2024 -- A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer...